ShresthaS. B.; BhusalM.; JwarchanJ.; GautamS.; ShresthaP. R. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients. Journal of Nepal Health Research Council, v. 20, n. 4, p. 881-885, 20 Jul. 2023.